BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31300419)

  • 41. Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines.
    Hernandez-Vargas H; Gruffat H; Cros MP; Diederichs A; Sirand C; Vargas-Ayala RC; Jay A; Durand G; Le Calvez-Kelm F; Herceg Z; Manet E; Wild CP; Tommasino M; Accardi R
    Sci Rep; 2017 Jul; 7(1):5852. PubMed ID: 28724958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR‑29 promoter and enhancer methylation identified by pyrosequencing in Burkitt lymhoma cells: Interplay between MYC and miR‑29 regulation.
    Mazzoccoli L; Robaina MC; Bacchi CE; Soares Lima SC; Klumb CE
    Oncol Rep; 2019 Aug; 42(2):775-784. PubMed ID: 31173259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential IgM expression distinguishes two types of pediatric Burkitt lymphoma in mouse and human.
    Eason AB; Sin SH; Lin C; Damania B; Park S; Fedoriw Y; Bacchi CE; Dittmer DP
    Oncotarget; 2016 Sep; 7(39):63504-63513. PubMed ID: 27566574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma.
    Gehringer F; Weissinger SE; Möller P; Wirth T; Ushmorov A
    Leukemia; 2020 Mar; 34(3):857-871. PubMed ID: 31719683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases.
    Shestakova A; Shao L; Smith LB; Ryan R; Bedell V; Murata-Collins J; Zhang W; Perry AM; Song JY
    Hum Pathol; 2023 Jun; 136():34-43. PubMed ID: 36997031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
    Seegmiller AC; Garcia R; Huang R; Maleki A; Karandikar NJ; Chen W
    Mod Pathol; 2010 Jul; 23(7):909-20. PubMed ID: 20348878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma.
    Seitz V; Butzhammer P; Hirsch B; Hecht J; Gütgemann I; Ehlers A; Lenze D; Oker E; Sommerfeld A; von der Wall E; König C; Zinser C; Spang R; Hummel M
    PLoS One; 2011; 6(11):e26837. PubMed ID: 22102868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is Burkitt's lymphoma?
    Wright DH
    J Pathol; 1997 Jun; 182(2):125-7. PubMed ID: 9274520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis.
    Roberto MP; Varano G; Vinas-Castells R; Holmes AB; Kumar R; Pasqualucci L; Farinha P; Scott DW; Dominguez-Sola D
    Immunity; 2021 Aug; 54(8):1807-1824.e14. PubMed ID: 34380064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
    Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.
    De Falco G; Leucci E; Lenze D; Piccaluga PP; Claudio PP; Onnis A; Cerino G; Nyagol J; Mwanda W; Bellan C; Hummel M; Pileri S; Tosi P; Stein H; Giordano A; Leoncini L
    Blood; 2007 Aug; 110(4):1301-7. PubMed ID: 17485552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
    Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retinoblastoma-related geneRb2/p130 are rarely mutated in Burkitt's lymphoma from Brazil.
    Klumb CE; Magluta EP; Rezende LM; Apa AG; Alonso JF; Maia RC
    Am J Hematol; 2007 Mar; 82(3):238-9. PubMed ID: 16955460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From the archives of MD Anderson Cancer Center: Sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression.
    Siddiqui SH; Thakral B; Aakash F; Ok CY; Tang Z; Medeiros LJ
    Ann Diagn Pathol; 2023 Oct; 66():152182. PubMed ID: 37543028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
    Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Stejskalová E; Kabícková E
    Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
    Gaidano G; Carbone A; Pastore C; Capello D; Migliazza A; Gloghini A; Roncella S; Ferrarini M; Saglio G; Dalla-Favera R
    Blood; 1997 May; 89(10):3755-62. PubMed ID: 9160681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of FOXO1 mutations in diffuse large B-cell lymphoma.
    Trinh DL; Scott DW; Morin RD; Mendez-Lago M; An J; Jones SJ; Mungall AJ; Zhao Y; Schein J; Steidl C; Connors JM; Gascoyne RD; Marra MA
    Blood; 2013 May; 121(18):3666-74. PubMed ID: 23460611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.
    Woroniecka R; Rymkiewicz G; Szafron LM; Blachnio K; Szafron LA; Bystydzienski Z; Pienkowska-Grela B; Borkowska K; Rygier J; Kotyl A; Malawska N; Wojtkowska K; Parada J; Borysiuk A; Murcia Pienkowski V; Rydzanicz M; Grygalewicz B
    PLoS One; 2022; 17(2):e0263980. PubMed ID: 35167621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.